Module Key Takeaways

• In the context of limited supply of the COVID-19 vaccine, vaccination alone will not be sufficient to prevent community-level transmission. Therefore, public health and social measures (i.e., using face masks and physical distancing) should continue to be used.
• The key objectives of the COVID-19 vaccination are:
• Protecting the integrity of the healthcare system.
• Reducing morbidity and mortality.
• Restoring social and economic functionality.
• Ultimately reaching population immunity and reducing transmission of COVID-19.
• Stability data of candidate vaccines are not yet available and currently no COVID-19 vaccine is prequalified by WHO.
• Vaccine wastage rate of 15% will be used to calculate the total amount of vaccine per target.
• Ensure all vaccines and diluents are kept in their original secondary packaging and are clearly labeled.
• Do not return opened vaccine vials to the cold chain. Discard them according to existing standard operating procedures.
• Reverse logistics is the process of retrieving unused vaccines to either dispose or reuse.
• Use AD syringes and dispose of them as sharps waste.
• Ensure standard infection prevention and control strategies for vaccination sessions.
• Follow the seven steps to safe injection while administering COVID-19 vaccine.
• AEFI is any untoward medical occurrence which follows immunization.
• Follow manufacturer’s recommendations on storage, vaccine preparation, route and technique of administration, and contraindications and precautions to prevent immunization error-related AEFI.
• When sudden loss of consciousness occurs >5–10 minutes after immunization, anaphylaxis should be considered as a possible diagnosis, in addition to fainting (vasovagal syncope).
• Proper recording and reporting provides a certified proof of vaccination, serves to monitor progress with vaccine uptake and coverage, and provides information for vaccine and supply management.
• Good communication helps create and maintain respect and trust between health workers, families and communities.
• Tailoring messages by risk groups will help people understand why they are eligible and build trust and confidence in the vaccine.